Simplex Trading
NVO

Simplex Trading’s Novo Nordisk NVO Stock Holding History

Simplex Trading’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$71M Sell
1,933,100
-35,700
-2% -$1.69M 0.05% 165
2025
Q4 		$100M Buy
1,968,800
+340,300
+21% +$17.4M 0.06% 157
2025
Q3 		$90.4M Buy
1,628,500
+411,600
+34% +$24.1M 0.05% 213
2025
Q2 		$84M Buy
1,216,900
+260,500
+27% +$17.7M 0.05% 186
2025
Q1 		$66.4M Buy
956,400
+31,000
+3% +$2.56M 0.04% 203
2024
Q4 		$79.6M Buy
925,400
+123,100
+15% +$13.3M 0.04% 202
2024
Q3 		$95.5M Sell
802,300
-142,700
-15% -$19M 0.06% 172
2024
Q2 		$135M Sell
945,000
-82,700
-8% -$11M 0.08% 112
2024
Q1 		$132M Buy
1,027,700
+181,300
+21% +$21.6M 0.08% 128
2023
Q4 		$87.6M Sell
846,400
-142,700
-14% -$14.1M 0.06% 206
2023
Q3 		$89.9M Buy
989,100
+492,300
+99% +$43.4M 0.07% 155
2023
Q2 		$40.2M Buy
496,800
+253,400
+104% +$20.7M 0.03% 325
2023
Q1 		$19.4M Buy
243,400
+139,200
+134% +$9.87M 0.02% 601
2022
Q4 		$7.05M Sell
104,200
-57,400
-36% -$3.37M 0.01% 1032
2022
Q3 		$8.05M Buy
161,600
+128,400
+387% +$6.88M 0.01% 902
2022
Q2 		$1.85M Sell
33,200
-46,200
-58% -$2.56M ﹤0.01% 1962
2022
Q1 		$4.41M Buy
79,400
+56,400
+245% +$2.89M ﹤0.01% 1355
2021
Q4 		$1.29M Buy
23,000
+8,200
+55% +$444K ﹤0.01% 2525
2021
Q3 		$624K Hold
14,800
– – ﹤0.01% 3752
2021
Q2 		$619K Buy
14,800
+14,606
+7,529% +$566K ﹤0.01% 3825
2021
Q1 		$653K Sell
194
-740
-79% -$26.4K ﹤0.01% 2972
2020
Q4 		$3.26M Buy
934
+156
+20% +$5.39K ﹤0.01% 1319
2020
Q3 		$2.7M Sell
778
-140
-15% -$4.67K ﹤0.01% 1290
2020
Q2 		$3M Buy
918
+116
+14% +$3.7K ﹤0.01% 1188
2020
Q1 		$2.41M Buy
802
+260
+48% +$7.74K ﹤0.01% 1135
2019
Q4 		$1.57M Sell
542
-836
-61% -$23.1K ﹤0.01% 1696
2019
Q3 		$3.56M Buy
1,378
+1,086
+372% +$27.5K 0.01% 910
2019
Q2 		$745K Buy
292
+132
+83% +$3.26K ﹤0.01% 2186
2019
Q1 		$418K Sell
160
-86
-35% -$2.11K ﹤0.01% 2842
2018
Q4 		$566K Sell
246
-274
-53% -$6.09K ﹤0.01% 2105
2018
Q3 		$1.23M Buy
520
+62
+14% +$1.51K ﹤0.01% 1687
2018
Q2 		$1.06M Buy
458
+56
+14% +$1.33K ﹤0.01% 1737
2018
Q1 		$48K Buy
402
+272
+209% +$7.14K ﹤0.01% 2488
2017
Q4 		$15K Buy
130
+68
+110% +$1.73K ﹤0.01% 3574
2017
Q3 		$2K Sell
62
-568
-90% -$12.8K ﹤0.01% 5115
2017
Q2 		$16K Sell
630
-162
-20% -$3.27K ﹤0.01% 3532
2017
Q1 		$46K Buy
792
+126
+19% +$2.19K ﹤0.01% 2451
2016
Q4 		$65K Buy
666
+164
+33% +$2.97K ﹤0.01% 1901
2016
Q3 		$109K Buy
502
+436
+661% +$10.8K 0.01% 1462
2016
Q2 		$5K Buy
66
+2
+3% +$55 ﹤0.01% 4259
2016
Q1 		$2K Buy
64
+14
+28% +$375 ﹤0.01% 4767
2015
Q4 		$1K Sell
50
-186
-79% -$5.15K ﹤0.01% 4941
2015
Q3 		$25K Buy
236
+198
+521% +$5.61K ﹤0.01% 2588
2015
Q2 		$2K Buy
+38
New +$1.07K ﹤0.01% 4314
2015
Q1 		– Sell
-18
Closed -$2K – 5395
2014
Q4 		$2K Buy
+18
New +$402 ﹤0.01% 3788

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Simplex Trading's NVO Position: Q1 2026 in Review

Simplex Trading reduced its Novo Nordisk (NVO) stake by 61% in Q1 2026, selling an estimated $29.6M and leaving 392,803 shares worth $14.4M. The position accounts for 0.01% of the portfolio, ranked #542.

Simplex Trading first reported a position in NVO in Q1 2015 and has held it in 30 quarters since. The position peaked at $51.8M in Q4 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Simplex Trading held 392,803 shares of Novo Nordisk worth $14.4M as of Q1 2026.
  • Simplex Trading sold 624,359 Novo Nordisk shares in Q1 2026, an estimated $29.6M.
  • Novo Nordisk made up 0.01% of Simplex Trading's portfolio in Q1 2026, its #542 holding.
  • Simplex Trading first reported a position in Novo Nordisk in Q1 2015 and has held it in 30 quarters since.
  • Simplex Trading's Novo Nordisk position peaked at $51.8M in Q4 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.